- Home
- TFIN vs BHVN Comparison
TFIN vs BHVN Comparison
Compare TFIN & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TFIN | BHVN |
|---|---|---|
| Founded | 1981 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | TFIN | BHVN |
|---|---|---|
| Price | $60.62 | $10.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 16 |
| Target Price | ★ $62.00 | $29.79 |
| AVG Volume (30 Days) | 204.7K | ★ 4.4M |
| Earning Date | 01-21-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $412,291,000.00 | N/A |
| Revenue This Year | $10.27 | N/A |
| Revenue Next Year | $9.56 | $2,219.74 |
| P/E Ratio | $218.27 | ★ N/A |
| Revenue Growth | ★ 3.78 | N/A |
| 52 Week Low | $42.90 | $7.48 |
| 52 Week High | $105.26 | $45.87 |
Technical Indicators
Market Signals| Indicator | TFIN | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 67.56 | 49.90 |
| Support Level | $54.22 | $8.29 |
| Resistance Level | $56.66 | $10.18 |
| Average True Range (ATR) | 2.34 | 0.76 |
| MACD | 0.93 | 0.34 |
| Stochastic Oscillator | 82.61 | 90.59 |
Price Performance
Historical ComparisonAbout TFIN Triumph Financial Inc.
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.